Satoshi Nakano
- Neurology top 2%
- Amyotrophic Lateral Sclerosis Research 10
- Neurological diseases and metabolism 6
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis 9
- Genetics top 5%
- Neurogenetic and Muscular Disorders Research 9
- Endocrinology top 5%
- Molecular Medicine top 5%
-
- Inflammatory Myopathies and Dermatomyositis 12
- Pneumonia and Respiratory Infections 11
-
- Muscle Physiology and Disorders 10
-
- Cardiomyopathy and Myosin Studies 6
- Co-authors
- Hirofumi KusakaHidefumi ItoReika WateIchiro AkiguchiMiki NagaoMasaki YamamotoYasufumi MatsumuraYasuhiro Kawamoto
- Cited by
- NeurologyHepatologyGenetics
- Partner nations
- JapanUnited StatesAustralia
In The Last Decade
Satoshi Nakano
120 papers receiving 2.5k citations
Peers
Comparison fields: 5 of 130
- Neurology 707
- Hepatology 246
- Genetics 289
- Endocrinology 135
- Molecular Medicine 121
Countries citing papers authored by Satoshi Nakano
This map shows the geographic impact of Satoshi Nakano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Satoshi Nakano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Satoshi Nakano more than expected).
Fields of papers citing papers by Satoshi Nakano
This network shows the impact of papers produced by Satoshi Nakano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Satoshi Nakano. The network helps show where Satoshi Nakano may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Satoshi Nakano, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 0 | |
| 4 | 2023 | 0 | |
| 5 | 2020 | 26 | |
| 6 | 2018 | 1 | |
| 7 | 2018 | 5 | |
| 8 | 2018 | 10 | |
| 9 | 2016 | 31 | |
| 10 | 2014 | 13 | |
| 11 | 2009 | 37 | |
| 12 | 2009 | 6 | |
| 13 | 2008 | 155 | |
| 14 | 2008 | 17 | |
| 15 | 2005 | 0 | |
| 16 | 1995 | 1 | |
| 17 | 1994 | 4 | |
| 18 | 1990 | 1 | |
| 19 | 1987 | 2 | |
| 20 | 1984 | 5 |
About Satoshi Nakano
Satoshi Nakano is a scholar working on Hepatology, Endocrinology and Epidemiology, having authored 128 papers that have together received 2.6k indexed citations. Recurring topics across this work include Inflammatory Myopathies and Dermatomyositis (12 papers), Pneumonia and Respiratory Infections (11 papers), Muscle Physiology and Disorders (10 papers), Amyotrophic Lateral Sclerosis Research (10 papers), Hepatocellular Carcinoma Treatment and Prognosis (9 papers), Neurogenetic and Muscular Disorders Research (9 papers), Neurological diseases and metabolism (6 papers) and Cardiomyopathy and Myosin Studies (6 papers). The work is most often cited by research in Neurology (707 citations), Hepatology (246 citations) and Genetics (289 citations). Satoshi Nakano has collaborated with scholars based in Japan, United States and Australia. Frequent co-authors include Hirofumi Kusaka, Hidefumi Ito, Reika Wate, Ichiro Akiguchi, Miki Nagao, Masaki Yamamoto, Yasufumi Matsumura, Yasuhiro Kawamoto, Jun Kimura and Satoshi Ichiyama. Their work appears in journals such as PLoS ONE, Analytical Chemistry and Brain.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.